...Diagnostics in 2000-2006.Imcyse S.A. announced Denis Bedoret has joined as CEO. He was CEO at MaSTherCell S.A. BC...

...has earmarked $330 million of the new funds to finance the deal its acquisition of MaSTherCell...

...its manufacturing capacity for new modalities via the $315 million acquisition of cell therapy company MaSTherCell...
...the growing competition for manufacturing capacity in new modalities. The takeout price is nearly 16x MaSTherCell’s...
...“$1.2 Billion Catalent-Paragon Deal Latest in Race to Lock Up Gene Therapy Manufacturing” ). Buying MaSTherCell...

...Founded: 2016 by Radforsk, Birk Venture and Inven2 University collaborators: Oslo University Hospital Corporate partners: MaSTherCell S.A....

...for it's late-stage European trials. MaSTherCell is a subsidiary of Orgenesis Inc. (NASDAQ: ORGS) through Masthercell...

...18% stake and was the second-largest shareholder. The other two exits were cell therapy manufacturer MaSTherCell S.A....

...women's health company Ogeda S.A. (Brussels, Belgium); cell therapy companies Promethera Biosciences S.A. (Mont-Saint-Guibert, Belgium), MaSTherCell S.A....